Olema Pharmaceuticals, Inc.
OLMA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $342 | $635 | $98 | $370 |
| - Cash | $139 | $69 | $24 | $287 |
| + Debt | $1 | $2 | $3 | $3 |
| Enterprise Value | $204 | $569 | $77 | $86 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$142 | -$105 | -$107 | -$71 |
| % Margin | – | – | – | – |
| Net Income | -$129 | -$97 | -$105 | -$71 |
| % Margin | – | – | – | – |
| EPS Diluted | -2.2 | -2.14 | -2.62 | -1.79 |
| % Growth | -2.8% | 18.3% | -46.4% | – |
| Operating Cash Flow | -$104 | -$84 | -$82 | -$51 |
| Capital Expenditures | -$0 | $0 | -$0 | -$2 |
| Free Cash Flow | -$105 | -$84 | -$82 | -$52 |